For following the competition: what moved in each program, several studies read as one move.
- Cohort A: DXC016 dose escalation
- DEC003M
- DXC008
- + 2 more
Mondays · ranked, phase 3 first · readouts ahead · See a sample brief
Add Hangzhou DAC Biotechnology to watchlistEvery Monday by email · turn it off any timePro · free during the beta